Zoll Medical Corporation: Heart Failure trials

The registry lists 16 Heart Failure studies with Zoll Medical Corporation as lead sponsor. 2 are open to participants now and 6 have results posted.

No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Remote Monitoring and Optimization of Heart Failure TherapyNot yet recruitingNCT07622472Not applicable
• Pre-hospital Ventilation Clinical StudyEnrolling by invitationNCT05604430
• Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH)CompletedNCT04512703Results posted
• Benefits of Microcor in Ambulatory Decompensated Heart FailureCompletedNCT04096040Not applicableResults posted
• Benefits of µCor in Ambulatory Decompensated Heart FailureCompletedNCT03476187Not applicableResults posted
• Heart Failure Optimization StudyCompletedNCT03016754Results posted
• Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD) StudyCompletedNCT02825966Not applicableResults posted
• LifeVest Trends Validation ProtocolCompletedNCT02149290Results posted
• Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients with Heart Failure with Reduced or Mildly Reduced Left Ventricular Ejection FractionCompletedNCT06313840
• Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter DefibrillatorTerminatedNCT04292405
• Heart Sounds RegistryCompletedNCT03203629
• LifeVest Wearable Cardioverter Defibrillator WEARIT-III RegistryCompletedNCT02700880
• Cardiovascular Diagnosis Using µ-Cor - an Interventional Pilot TrialWithdrawnNCT02700191Not applicable
• Prospective Evaluation of Heart Failure Patients With Central Sleep ApneaTerminatedNCT01414309
• Study of the Wearable Defibrillator in Heart-Failure PatientsCompletedNCT01326624
• Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac StimulationCompletedNCT01008670